Pain TherapeuticsStock Price and Value Analysis

Should you buy Pain Therapeutics stock? (NasdaqGS:PTIE). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company is not making money.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the PTIE Numbers

PTIE Price
(Pain Therapeutics stock price per share)
$4.24
[?] PE Ratio versus Sector 81% lower than other Healthcare stocks
[?] PE Ratio versus Industry 93% lower than other Biotechnology stocks
[?] Cash Yield -26.10%
[?] Free Cash Flow Jitter 4589%
[?] Dividend Yield 0%

Is Pain Therapeutics Stock on Sale?

Based on our analysis, we believe that you should not buy Pain Therapeutics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy PTIE Stock?

Does Pain Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.